JJ Mahoney - Am J Manag Care, 2005 - ajmc.com Abstract Concerned about rising prevalence and costs of diabetes among its
employees, Pitney Bowes Inc recently revamped its drug benefit design to syner-
gize with ongoing efforts in its disease management and patient education ... Cited by 39 - Related articles - View as HTML - All 5 versions
SA Stock, M Redaelli, G Wendland, D Civello … - Diabetic Medicine, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 28 - Related articles - BL Direct - All 4 versions
- ►escholarship.org J Klick, T Stratmann - The Journal of Law and Economics, 2007 - UChicago Press Featured in Wall Street Journal "Get the Feeling You're Being Watched? If You're
Driving, You Just Might Be" March 27, 2009 Red Ink in the Rearview Mirror: Local
Fiscal Conditions and the Issuance of Traffic Tickets Thomas Garrett and ... Cited by 6 - Related articles - BL Direct - All 15 versions
- ►gmu.edu [PDF] J Klick, T Stratmann - papers.ssrn.com Abstract: In the face of rising diabetes rates, many states passed laws
requiring health insurance plans to cover medical treatments for the disease. As
with most insurance, this coverage has the potential to induce moral hazard ... Related articles - All 3 versions
A Follow - Am J Manag Care, 2005 - ajmc.com Concerned about rising prevalence and costs of diabetes among its employees,
Pitney Bowes Inc recently revamped its drug benefit design to synergize with
ongoing efforts in its disease management and patient education programs. ... Related articles - Cached
A Forms - Am J Manag Care, 2005 - ajmc.com Concerned about rising prevalence and costs of diabetes among its employees,
Pitney Bowes Inc recently revamped its drug benefit design to synergize with
ongoing efforts in its disease management and patient education programs. ... Related articles - Cached - All 2 versions
K Summers, TJ Songer - Expert Review of Pharmacoeconomics and Outcomes …, 2003 - ingentaconnect.com The costs of diabetes are significant, approaching US$100 billion. Medical costs
for patients with diabetes are between two- and four-times higher per patient
per year when compared to persons without diabetes. Long-term complications ... Related articles - All 3 versions
A Scholze - ub.uni-bamberg.de Page 1. Angst vor Insulintherapie bei Typ-2-Diabetikern Inaugural-Dissertation
in der Fakultät Pädagogik, Philosophie und Psychologie ... Related articles - View as HTML - All 3 versions